Skip to main content
Fig. 3 | BMC Medicine

Fig. 3

From: Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinoma

Fig. 3

Venn diagram of response patterns. Percentage of 27 patients with the indicated combination of lesion response categories based on a the assessment of the best response achieved per lesion and b assessment on the specific scan showing the best overall response. RL Responding Lesion, SL Stable Lesion, PL Progressing Lesion

Back to article page

BMC Medicine

ISSN: 1741-7015

Contact us